OASMIA PHARMACEUTICAL AB's ticker is OASMY and the CUSIP is 67421W109. A total of 4 filers reported holding OASMIA PHARMACEUTICAL AB in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $179,000 | -15.2% | 203,170 | 0.0% | 0.10% | -7.3% |
| Q3 2017 | $211,000 | -1.4% | 203,170 | 0.0% | 0.11% | +6.9% |
| Q2 2017 | $214,000 | -43.2% | 203,170 | +2.9% | 0.10% | -51.7% |
| Q1 2017 | $377,000 | -26.4% | 197,470 | +8.3% | 0.21% | -29.4% |
| Q4 2016 | $512,000 | +40.3% | 182,270 | +49.3% | 0.30% | +18.7% |
| Q3 2016 | $365,000 | -13.9% | 122,100 | -0.7% | 0.25% | +16.1% |
| Q2 2016 | $424,000 | -18.9% | 123,000 | 0.0% | 0.22% | +13.6% |
| Q1 2016 | $523,000 | +17.5% | 123,000 | 0.0% | 0.19% | -3.0% |
| Q4 2015 | $445,000 | – | 123,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |